Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions

Status unconfirmed · Not applicable

Conditions studied: Pancreatic Tumor, Gastric Tumor, Esophageal Tumor, Lymphadenopathy, Duodenal Tumor

In brief

The purpose of this study is to determine if fine needle aspiration or fine needle biopsy is more efficacious and cost-effective than the other while maintaining diagnostic accuracy in the setting of solid gastrointestinal lesions.

Key facts

Study ID

NCT01698190

Run by

Stony Brook University

People needed

400

Starts

2011-12-01

Expected to finish

2014-12-01

Last updated by the study team

2014-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Consecutive adult patients who require endoscopic ultrasound and tissue sampling of either a) pancreatic solid lesion, b) subepithelial solid lesion of the esophagus, stomach, duodenum or rectum, c) liver lesion, or d) lymph nodes or mass lesion located adjacent to the esophagus, stomach, duodenum or rectum
• Ability to give consent

You may not qualify if…

• Inability to obtain informed consent
• Pregnant patients
• Patients under the age of 18
• Severe cardiopulmonary disease preventing a safe EUS procedure
• Patients unable to safely stop anti-coagulation therapy prior to EUS procedure

Where it is running

• Stony Brook University Hospital — Stony Brook, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.